This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (82)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

John H. Bauer, MD; Garry P. Reams, MD; Sunder M. Lal, MD

Arch Intern Med. 1987;147(8):1397-1400.

Abstract
• The effect of strict blood pressure control on progression of renal disease in patients with essential hypertension has not been well defined. We have followed prospectively for three years 23 patients with essential hypertension. Blood pressure was well controlled on either enalapril or enalapril-hydrochlorothiazide therapy. Yearly assessment of renal function revealed no change in glomerular filtration rate as assessed by creatinine or inulin clearance, and a sustained 17% increase in effective renal plasma flow. In patients with moderately impaired renal function (inulin clearance1.33 mL/s [80 mL/ min]), there was a first-year 50% increase in inulin clearance, and a 33% increase in inulin clearance at year three. In these patients, there was a 39% first-year increase in effective renal plasma flow, which was sustained at year three. Filtration fraction and urinary protein excretion were unchanged. These results suggest that long-term blood pressure control with the angiotensin-converting enzyme inhibitor enalapril or enalapril-hydrochlorothiazide is associated with preservation and/ or improvement in renal function.

(Arch Intern Med 1987;147:1397-1400)

Author Affiliations
From the Hypertension Section, Department of Medicine, University of Missouri School of Medicine, Columbia.

Footnotes
Accepted for publication May 12,1987.

Reprint requests to the School of Medicine, Department of Medicine, Division of Nephrology, Hypertension Section N403, University of Missouri-Columbia, Columbia, MO 65212 (Dr Bauer).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Current Strategies for Management of Hypertensive Renal Disease
Moore et al.
Arch Intern Med 1999;159:23-28.
ABSTRACT | FULL TEXT  

Achievement and Safety of a Low Blood Pressure Goal in Chronic Renal Disease: The Modification of Diet in Renal Disease Study Group*
Lazarus et al.
Hypertension 1997;29:641-650.
ABSTRACT | FULL TEXT  

1995 Update of the Working Group Reports on Chronic Renal Failure and Renovascular Hypertension
National High Blood Pressure Education Program Wor
Arch Intern Med 1996;156:1938-1947.
ABSTRACT  

Long-term Effects of Antihypertensive Agents on Proteinuria and Renal Function
Maki et al.
Arch Intern Med 1995;155:1073-1080.
ABSTRACT  

Lisinopril Improves Aortic Compliance and Renal Flow : Comparison With Nifedipine
Shimamoto and Shimamoto
Hypertension 1995;25:327-334.
ABSTRACT | FULL TEXT  

Angiotensin-Converting Enzyme Inhibition and Renal Protection: An Assessment of Implications for Therapy
Hollenberg and Raij
Arch Intern Med 1993;153:2426-2435.
ABSTRACT  

Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Chronic Renal Disease
ter Wee and Epstein
Arch Intern Med 1993;153:1749-1759.
ABSTRACT  

National High Blood Pressure Education Program Working Group Report on Hypertension and Chronic Renal Failure
National High Blood Pressure Education Program
Arch Intern Med 1991;151:1280-1287.
ABSTRACT  

Angiotensin Converting Enzyme Inhibitors and Progressive Renal Insufficiency: Current Experience and Future Directions
Keane et al.
ANN INTERN MED 1989;111:503-516.
ABSTRACT  

Enalapril Therapy in Patients With Renal Function Impairment
Bear
Arch Intern Med 1988;148:2343-2344.
ABSTRACT